Results 31 to 40 of about 34,574 (224)

Risk‐Stratified and Response‐Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience

open access: yesAdvances in Hematology, Volume 2025, Issue 1, 2025.
Background: The international cooperation between GATLA and AHOPCA with the support of St. Jude led to the adoption of the OEPA/COPDAC as a strategy to improve outcomes in high risk (HR) patients with HL. This study also includes the ABVD regimen for intermediate risk (IR) and low risk (LR) patients. Methods: Patients were stratified by predefined risk
David Veron   +11 more
wiley   +1 more source

Eosinofilorraquia em tumor maligno: apresentação de caso

open access: yesArquivos de Neuro-Psiquiatria, 1985
A presença de granulócitos eosinófilos associados a tumores malignos que acometem o sistema nervoso tem sido raramente comunicada. O propósito deste registro é apresentar o caso de um paciente com 47 anos de idade com tumor cerebral maligno (astrocitoma ...
João Baptista dos Reis Filho   +2 more
doaj   +1 more source

Increased Early‐Mortality in Children With Solid Tumors During the COVID‐19 Pandemic in a Middle‐Income Country

open access: yesCancer Medicine, Volume 13, Issue 24, December 2024.
During the COVID‐19 pandemic, an increase in the risk of early‐mortality in children with solid malignant tumors was observed, specifically in bone tumors and retinoblastoma. Furthermore, patients were diagnosed at more advanced stages and the main cause of death was progressive disease.
Oscar Ramirez   +76 more
wiley   +1 more source

UEG Week 2023 Poster Presentations

open access: yes, 2023
United European Gastroenterology Journal, Volume 11, Issue S8, Page 535-1498, October 2023.
wiley   +1 more source

Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study

open access: yesEuropean Journal of Neurology, Volume 31, Issue 12, December 2024.
Abstract Background and purpose Although there is extensive evidence about the safety of monoclonal antibodies against calcitonin gene‐related peptide (anti‐CGRP mAbs) in combination with traditional drugs, scarce data are available on the safety of their combination with other mAbs.
Luigi Francesco Iannone   +34 more
wiley   +1 more source

Análise do registro hospitalar de câncer infanto-juvenil de um centro de referência em Santa Catarina no período de 1999-2003 [PDF]

open access: yes, 2004
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Silva, Heitor Tognoli
core  

Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry

open access: yesHemaSphere, Volume 8, Issue 11, November 2024.
Abstract Asymptomatic IgM gammopathy encompasses IgM monoclonal gammopathy of undetermined significance (MGUS) and asymptomatic Waldenström macroglobulinemia (AWM), both having a risk of progression to symptomatic disease. Here, we assessed the risk of progression and the mortality of 956 patients with asymptomatic IgM gammopathy across 25 Spanish ...
David F. Moreno   +17 more
wiley   +1 more source

Tumores neuroblásticos de mediastino na criança. [PDF]

open access: yes, 2001
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Pediatria, Curso de Medicina, Florianópolis ...
Machry, Joana Silva
core  

Estudio epidemiológico de carcinoma escamoso de piel en el área de Barcelonés Nord [PDF]

open access: yes, 2012
El carcinoma escamós de pell representa una de les neoplàsies més freqüents de la raça blanca. En aquest treball es pretén estimar la seva incidència acumulada a l'àrea del Barcelonès Nord.
Medved, Georgiy   +2 more
core  

Frequency of use and annual costs of biological therapy for psoriasis in Colombia in 2019

open access: yesInternational Journal of Dermatology, Volume 63, Issue 11, Page e296-e301, November 2024.
Abstract Background Evidence describing the types and annual costs of biological treatments for psoriasis in Latin America is scarce. This study aimed to estimate the frequency of use and costs of biologic therapy for psoriasis in Colombia in 2019. Methods This secondary data analysis uses the International Classification of Diseases terms associated ...
Daniel G. Fernández‐Ávila   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy